Big Moving Stocks for Jul-15 At The Close

These stocks are posting some big moves for today.

BG Medicine Inc (BGMD) < (BGMD) is currently trading at $2.30 + 0.7601 (49.36%) on 2,181,234 shares traded. BG Medicine Inc (BGMD) < is +24.73% year-to-date, and -41.67% over the last 12 months.

BG Medicine Inc is engaged in developing and commercializing diagnostic products that may be used to help guide the care and management of patients who suffer from heart failure and related disorders. Its product includes BGM Galectin-3 test.

ITUS Corp (ITUS) < (ITUS) is currently trading at $4.75 + 1.27 (36.59%) on 47,100 shares traded. ITUS Corp (ITUS) < is +72.73% year-to-date, and -22.48% over the last 12 months.

ITUS Corp funds, develops, acquires and licenses emerging technologies. The Company’s areas of interest include High-Tech, Biotechnology, Life Sciences, and Informatics. Its licensing programs involve encrypted communications, and advanced materials.

TRACON Pharmaceuticals Inc (TCON) < (TCON) is currently trading at $13.23 + 2.53 (23.64%) on 118,405 shares traded. TRACON Pharmaceuticals Inc (TCON) < is -- year-to-date, and -- over the last 12 months.

TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.

PTC Therapeutics Inc. (PTCT) < (PTCT) is currently trading at $56.79 + 7.85 (16.04%) on 1,613,514 shares traded. PTC Therapeutics Inc. (PTCT) < is +9.70% year-to-date, and +130.36% over the last 12 months.

PTC Therapeutics Incu00A0is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.

Ohr Pharmaceutical Inc. (OHRP) < (OHRP) is currently trading at $3.72 + 0.45 (13.76%) on 14,337,326 shares traded. Ohr Pharmaceutical Inc. (OHRP) < is -55.40% year-to-date, and -51.29% over the last 12 months.

Ohr Pharmaceutical Inc is a pharmaceutical company engaged in the development of the Company’s previously acquired compounds.

Magellan Petroleum Corporation (MPET) < (MPET) is currently trading at $2.95 + 0.3199 (12.16%) on 20,026 shares traded. Magellan Petroleum Corporation (MPET) < is -59.48% year-to-date, and -82.85% over the last 12 months.

Magellan Petroleum Corp is an oil and gas exploration and production company. It is engaged in the development of CO2-enhanced oil recovery in eastern Montana and the exploration of unconventional hydrocarbon resources in the Weald Basin, onshore UK.

Zogenix Inc. (ZGNX) < (ZGNX) is currently trading at $19.82 + 2.13 (12.04%) on 2,919,455 shares traded. Zogenix Inc. (ZGNX) < is +80.84% year-to-date, and +49.47% over the last 12 months.

Zogenix Inc is a pharmaceutical company engaged in commercializing & developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.

Helios & Matheson Analytics Inc (HMNY) < (HMNY) is currently trading at $2.46 + 0.2519 (11.40%) on 300 shares traded. Helios & Matheson Analytics Inc (HMNY) < is +23.11% year-to-date, and -48.72% over the last 12 months.

Helios and Matheson Analytics Inc provides IT solutions and services. Its services include application value management, application development, integration, independent validation and infrastructure services.

Receptos Inc. (RCPT) < (RCPT) is currently trading at $229.38 + 22.20 (10.72%) on 8,005,134 shares traded. Receptos Inc. (RCPT) < is +87.23% year-to-date, and +527.43% over the last 12 months.

Receptos Inc is a biopharmaceutical company engaged in discovering, developing and commercializing therapeutics for immune disorders. Its product candidates span three distinct specialty disease areas.

Recro Pharma Inc (REPH) < (REPH) is currently trading at $15.91 + 1.49 (10.33%) on 145,602 shares traded. Recro Pharma Inc (REPH) < is +456.29% year-to-date, and +123.88% over the last 12 months.

Recro Pharma Inc a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially in the post-operative setting.

Alex Fredricks

Alex Fredricks

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.